Controlled release of bovine serum albumin using MPEG-PCL diblock copolymers as implantable protein carriers

14Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

MPEG-PCL diblock copolymers consisting of methoxy polyethylene glycol (MPEG) and poly(ε-caprolactone) (PCL) as drug carriers were synthesized by ringopening polymerization. It is possible to control the balance between hydrophilic and hydrophobic by changing the MPEG and the ratio of ε-CL to MPEG. Implantable wafers were easily fabricated by the direct compression method after physical mixing of diblock copolymers and bovine serum albumin-fluorescein isothiocyanate (BSA-FITC) as a model protein drug. The BSA release from wafers prepared by MPEG-PCL diblock copolymers were higher than that from PCL with the physical blending of MPEG. The wafers prepared by a variety of MPEG-PCL diblock copolymers exhibited the controlled BSA release profiles with a dependence on MPEG-PCL diblock copolymer compositions. In addition, the changing of MPEG and PCL molecular weights within MPEG-PCL diblock copolymer controlled the initial burst of BSA. We confirmed that the diblock copolymers could be served as protein delivery carrier in implantable wafer form. © 2006 Wiley Periodicals, Inc.

Cite

CITATION STYLE

APA

Kim, M. S., Seo, K. S., Hyun, H., Khang, G., Cho, S. H., & Lee, H. B. (2006). Controlled release of bovine serum albumin using MPEG-PCL diblock copolymers as implantable protein carriers. Journal of Applied Polymer Science, 102(2), 1561–1567. https://doi.org/10.1002/app.23528

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free